Rate-of-change dependence of the performance of two CGM systems during induced glucose swings

Journal of Diabetes Science and Technology

Volumn 9, Issue 4, 2015, Pages 801-807

  Pleus, Stefan ^a   Schoemaker, Michael ^b   Morgenstern, Karin ^b   Schmelzeisen Redeker, Günther ^b   Haug, Cornelia ^a   Link, Manuela ^a   Zschornack, Eva ^a   Freckmann, Guido ^a  

^a UNIVERSITY OF ULM   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Accuracy; Continuous glucose monitoring; MARD; PARD; Rate of change

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ACCURACY; ANALYTICAL PARAMETERS; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLUCOSE SWING; HUMAN; HYPOGLYCEMIA; MEAN ABSOLUTE RELATIVE DIFFERENCE; PRECISION ABSOLUTE RELATIVE DIFFERENCE; RATE OF CHANGE; RETROSPECTIVE STUDY; SELF MONITORING BLOOD GLUCOSE SYSTEM; ADULT; ALGORITHM; ANALYSIS; BLOOD; CALIBRATION; COMPARATIVE STUDY; DEVICES; DIABETES MELLITUS; EQUIPMENT DESIGN; FEMALE; MALE; MIDDLE AGED; PHYSIOLOGIC MONITORING; PROCEDURES; REPRODUCIBILITY; SIGNAL PROCESSING; YOUNG ADULT;

ADULT; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CALIBRATION; DIABETES MELLITUS; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SIGNAL PROCESSING, COMPUTER-ASSISTED; YOUNG ADULT;

EID: 85018198300     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296815578716     Document Type: Article

References (30)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
2. IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med. 2006;23(6):579-593.
3. Bailey TS, Ahmann A, Brazg R, et al. Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes Technol Ther. 2014;16(5):277-283.
4. Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ. A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol. 2014;8:699-708.
5. Klaff LJ, Brazg R, Hughes K, et al. Accuracy evaluation of Contour Next compared with five blood glucose monitoring systems across a wide range of blood glucose concentrations occurring in a clinical research setting. Diabetes Technol Ther. 2015;17:8-15.
6. Freckmann G, Pleus S, Link M, Zschornack E, Klotzer HM, Haug C. Performance evaluation of three continuous glucose monitoring systems: comparison of six sensors per subject in parallel. J Diabetes Sci Technol. 2013;7(4):842-853.
7. Halldorsdottir S, Warchal-Windham ME, Wallace JF, Pardo S, Parkes JL, Simmons DA. Accuracy evaluation of five blood glucose monitoring systems: the North American comparator trial. J Diabetes Sci Technol. 2013;7(5):1294-1304.
8. Pleus S, Schmid C, Link M, et al. Performance evaluation of a continuous glucose monitoring system under conditions similar to daily life. J Diabetes Sci Technol. 2013;7(4):833-841.
9. Basu A, Dube S, Veettil S, et al. Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes. J Diabetes Sci Technol. 2015;9:63-68
10. Steil GM, Rebrin K, Hariri F, et al. Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia. 2005;48(9):1833-1840.
11. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 2003;52(11):2790-2794.
12. Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care. 2003;26(8):2405-2409.
13. Thennadil SN, Rennert JL, Wenzel BJ, Hazen KH, Ruchti TL, Block MB. Comparison of glucose concentration in interstitial fluid, and capillary and venous blood during rapid changes in blood glucose levels. Diabetes Technol Ther. 2001;3(3):357-365.
14. Sternberg F, Meyerhoff C, Mennel FJ, Mayer H, Bischof F, Pfeiffer EF. Does fall in tissue glucose precede fall in blood glucose? Diabetologia. 1996;39(5):609-612.
15. Schmelzeisen-Redeker G, Staib A, Strasser M, Müller U, Schoemaker M. Overview of a novel sensor for continuous glucose monitoring. J Diabetes Sci Technol. 2013;7(4):808-814.
16. Clinical and Laboratory Standards Institute. Performance metrics for continuous interstitial glucose monitoring; approved guideline. Available at: http://shopping.netsuite.com/c.1253739/site/Sample-pdf/POCT05A-sample.pdf. Accessed June 24, 2014.
17. Bailey TS, Chang A, Christiansen M. Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol. 2015;9:209-214.
18. Damiano ER, El-Khatib FH, Zheng H, Nathan DM, Russell SJ. A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care. 2013;36(2):251-259.
19. Luijf YM, Mader JK, Doll W, et al. Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. Diabetes Technol Ther. 2013;15(8):722-727.
20. Zschornack E, Schmid C, Pleus S, et al. Evaluation of the performance of a novel system for continuous glucose monitoring. J Diabetes Sci Technol. 2013;7(4):815-823.
21. Dexcom. FDA approves Dexcom software with artificial pancreas algorithm. Available at: http://www.dexcom.com/news/1766768139-fda-approves-dexcom-software-artificialpancreas-algorithm. Accessed February 5, 2015.
22. Bailey T, Zisser H, Chang A. New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time. Diabetes Technol Ther. 2009;11(12):749-755.
23. Zisser HC, Bailey TS, Schwartz S, Ratner RE, Wise J. Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements. J Diabetes Sci Technol. 2009;3(5):1146-1154.
24. Koivikko ML, Karsikas M, Salmela PI, et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia. 2008;51(3):426-435.
25. Wright RJ, Newby DE, Stirling D, Ludlam CA, Macdonald IA, Frier BM. Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care. 2010;33(7): 1591-1597.
26. Snell-Bergeon JK, Wadwa RP. Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol Ther. 2012;14(suppl 1):S51-S58.
27. Dave KR, Tamariz J, Desai KM, et al. Recurrent hypoglycemia exacerbates cerebral ischemic damage in streptozotocininduced diabetic rats. Stroke. 2011;42(5):1404-1411.
28. Rana O, Byrne CD, Kerr D, et al. Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans. Circulation. 2011;124(14):1548-1556.
29. MacLeod KM, Hepburn DA, Deary IJ, et al. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia. 1994;37(3): 257-263.
30. Jungheim K, Kapitza C, Djurhuus C, Wientjes K, Koschinsky T, Glucose Monitoring Study Group. How rapid does blood glucose concentration change in daily-life of patients with type 1 diabetes? Diabetologia. 2002;45(suppl2):A276.